Standard Dosage Range
Research dosing range: No established therapeutic range. Research doses vary widely.
Educational reference only
Dosage by Use Case
Gallbladder Function Testing (Sincalide)
Single administration
Sincalide (CCK-8 analog) is FDA-approved for gallbladder ejection fraction measurement. Administered intravenously by medical professionals.
Satiety Research
Single administration
Primarily used in research settings to study appetite regulation. Dosage varies significantly based on analog and route (IV, subcutaneous).
Pancreatic Enzyme Stimulation
Single administration
Used in research to assess pancreatic function. Dosage is highly variable and dependent on the specific CCK analog used.
Timing & Frequency
For gallbladder function testing, sincalide is administered intravenously. For satiety research, analogs are administered shortly before meals. The short half-life necessitates acute administration for effects.
Cycle Guidance
Not applicable. CCK analogs are not used in cyclic therapeutic regimens. Research and diagnostic applications involve single or short-term administrations.
Reconstitution Reference
Quick reference for reconstituting Cholecystokinin. For custom vial sizes and concentrations, use the Reconstitution Calculator.
| Common Vial Size | Varies by manufacturer |
| BAC Water Volume | Follow manufacturer instructions |
| Concentration & Draw | Varies. Follow manufacturer instructions for appropriate dilution. |
| Storage | Follow manufacturer instructions for reconstituted solutions. |
| Stability | Refer to manufacturer specifications for stability information. |
Frequently Asked Questions
What is the dosage of sincalide for gallbladder testing?
Are there any therapeutic uses for CCK?
Last updated: 2026-02-19